IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$10.29
+0.10 (+0.98%)
Performance
1D
—
1W
—
1M
—
3M
+144.42%
6M
+193.16%
1Y
+112.60%
YTD
+112.60%
Open$10.19
Previous Close$10.19
Day High$10.32
Day Low$10.03
52W High$10.98
52W Low$1.76
Volume—
Avg Volume14.32M
Market Cap4.54B
P/E Ratio—
EPS$-0.72
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.30
Above
RSI (14)
55.3
Neutral
Analyst Ratings
Strong Buy
15 analysts
Price Target
+432.3% upside
Current
$10.29
$10.29
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 338.41M | 337.04M | 333.93M |
| Net Income | -502,110,478 | 23.64M | 18.09M |
| Profit Margin | -148.4% | 7.0% | 5.4% |
| EBITDA | -471,867,282 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |